logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Incyte Corporation Skyrockets on Promising Trial for Jakafi

  +Follow August 21, 2013 9:20AM
Share:
Tickers Mentioned:

Pharmaceutical company Incyte Corporation (INCY) released very positive news on Aug. 21, revealing that their pancreatic cancer treatment drug ruxolitinib, marketed under the trade name Jakafi, had performed very well in Phase II trials, and that the drug could now move on to Phase III.

Incyte Executive Vice President Richard S. Levy pointed out that sufferers from advanced pancreatic cancer currently have very few options. If approved, the orally-administered drug would be one of the first on the market that exists as "an attractive treatment option" for sufferers of pancreatic cancer.

If approved by the FDA, this would be a major breakthrough. Metastatic pancreatic cancer has the lowest survival rate of any form of cancer. Currently, less than one percent of people afflicted survive more than five years.

Jakafi's ability to increase lifespan for sufferers looks very promising. In the Phase II trials, the six month survival rate for patients (when coupled with chemotherapy treatment) for Jakafi was 42 percent, compared to 11 percent for patients on a placebo.

Jakafi was first approved by the Food and Drug Administration in 2011 to treat a bone marrow disease. After its success in that arena, the company specualted that the drug might effectively treat other types of cancer as well. Now, the drug is fast aproaching approval to treat pancreatic cancer as well. Though it is currently the only drug the company has gotten passed by the USFDA. Jakafi seems to be fulfilling early analyst speculation that it could be a billion dollar blockbuster drug for the Delaware-based drug maker.

Incyte earned $54.1 million from sales of Jakafi in the second quarter of 2013, and expects to earn between $220 and $230 million total this year.

Incyte rocketed on the news, and went up 29.19 percent to hit $34.88 a share. They’re up 58.82 percent on the year.

(image courtesy of Wikimedia commons)

Results for INCY
Mind Equity
18 Apr 14 01:01:47
$INCY Incyte to Report First Quarter http://t.co/SxgJlkEkSM
Serge Adams
18 Apr 14 00:27:23
Regretting your investment in $INCY $ACE $FRX $RT Give it a try http://t.co/Xq3DeCAirh
Laird McQuillen
17 Apr 14 23:32:18
#Stocks you might want to hold onto $INCY $FRC $GCI $CI Must see http://t.co/3j8GV7kP6y
Stock_Tracker
17 Apr 14 19:37:53
Incyte Corp (INCY) 44.54 $INCY Incyte to Report First Quarter 2014 Financial Results on May 1 Business Wire - http://t.co/iEksJIMdrA
Kamren Dissana
17 Apr 14 18:51:03
$FLT Are you looking for winners like $INCY $CNA $CLF #newsletter http://t.co/mOiEpYnpTu
Jaycob Keating
17 Apr 14 17:04:55
Keeping my Eye on $INCY $ACE $SLB $AIG #wealthmanagement http://t.co/2AGRpQWIuQ
Inga Chisholmz
17 Apr 14 16:18:44
$RGA Todays movers to research $INCY $PLCM $LGND #Research http://t.co/uekPlz3qWN
Jabari Cageyi
17 Apr 14 16:12:50
$AVY #Stocks you might want to sell $INCY $LLTC $RAX #overvalued http://t.co/57TWU7cUr6
Pike Dean
17 Apr 14 15:33:44
Are you thinking of selling $LAMR $CSL $INCY $FB #Research http://t.co/8PRMMLZ6MD
Major Brown
17 Apr 14 14:26:43
Are you considering selling $INCY $HOLX $NEE $LGND #wealthmanagement http://t.co/3ykPuvd4So
Hoyt Britt
17 Apr 14 13:02:13
$COF Get more info on $INCY $KRC $OPK Give it a try http://t.co/b3sFxWOcx5
Belia Deleon
17 Apr 14 11:22:59
Are you considering selling $WYN $MSI $INCY $SLW #liquidity http://t.co/McCkEIlBt7
Calloway Domville
17 Apr 14 11:11:50
It could be breaktout time on $ATI $DGX $INCY $LIVE #equity http://t.co/AbWN3o4PcK
Sky Grady
17 Apr 14 10:11:03
Get the latest on $AJG $PG $INCY $CLF Click http://t.co/1kTMfywHDG
Yahaira Landry
17 Apr 14 09:23:11
Looking for the next winners like $AOS $XOM $INCY $BLOX #financial http://t.co/NGtJZfq9gG
Kohen Fisher
17 Apr 14 09:22:36
Get the latest on $KOS $XLS $INCY $USD Give it a try http://t.co/HcygMtBlO6
COCKRELL GROUP
17 Apr 14 09:13:39
Terence Flynn analyst of Goldman Sachs changes: Gilead $GILD, $63 from $68; Incyte $INCY, $32 from $33; Infinity Pharma $INFI, $14 from $16.
US_proptrader
17 Apr 14 08:59:34
$ACAD $ARIA $ARWR $ATHL $GRPN $INCY $ITMN $TPLM $VIPS autocharts @ http://t.co/kn4mViMgNq
Investment Ace
17 Apr 14 08:32:15
$INCY Incyte to Report First Quar http://t.co/zizSPNXpMh
Stock Pilot
17 Apr 14 08:22:39
$JW Small-cap stocks making 52-wk highs $INCY $ZNGA $RT #NSE http://t.co/AlTBeIiQmY
Legend Boulstridge
17 Apr 14 08:22:05
Todays movers to research $INCY $PWR $BIO $NUAN Check out http://t.co/hpo8PJdFu3
Fox Galvan
17 Apr 14 08:21:04
$INCY Incyte to Report First Quar http://t.co/gpBXdaa6L5
Lilly Bynum
17 Apr 14 08:18:40
#Stocks you migh want to Sell $COF $INCY $CBG $QLYS #wallstreet http://t.co/dsg50aWM90
Alexander Morris
17 Apr 14 07:48:04
$INCY: 3mRunaway+:2 [+3%,.7%offHi], tf:3e; TLM:1.8; ILM:1.4, AvgDyV/R=4.86M/3.30[x0.9] (PotLONG); vl:7; rs:+85
Calloway Domville
17 Apr 14 07:36:04
Stocks to Watch this week $MDR $AVB $INCY $CHTP #NSE http://t.co/q8sZQksiDV
BATTLE THE BTK
17 Apr 14 07:26:45
RT @ianestepan: $IMGN ~580k to buy $INCY ~265k to buy $ITMN ~1.2MM for sale $MYGN ~900k for sale $PCYC ~185k to buy
Patrick Crutcher
17 Apr 14 07:26:13
RT @ianestepan: $IMGN ~580k to buy $INCY ~265k to buy $ITMN ~1.2MM for sale $MYGN ~900k for sale $PCYC ~185k to buy
Ian Estepan
17 Apr 14 07:25:02
$IMGN ~580k to buy $INCY ~265k to buy $ITMN ~1.2MM for sale $MYGN ~900k for sale $PCYC ~185k to buy
Major Brown
17 Apr 14 07:19:41
#Stock Market Reports you need on $INCY $BBY $BMC $NUAN Click http://t.co/yEA8PCSErK
Large Void Bot
17 Apr 14 07:17:08
Daily Reversal (10:17): $INCY Last: 44.90; pHigh: 44.70; rVol: 1.818; pClose: 43.98; LOD: 43.13; Perf: 2.1%
Horacio Campbell
17 Apr 14 07:15:36
Todays Stocks you should be watching $INCY $TE $ROC $FB #equity http://t.co/R52fJT0FOw
US_proptrader
17 Apr 14 07:10:24
$AAL $ARWR $BBRY $CAR $DUST $GOGO $HZNP $INCY $SUNE autocharts @ http://t.co/kn4mViMgNq
US_proptrader
17 Apr 14 07:08:35
$AAL $ARWR $ATHL $BBRY $CAR $GOGO $HZNP $INCY $SUNE autocharts @ http://t.co/kn4mViMgNq
Candance Stull
17 Apr 14 07:04:38
Should you buy $INCY $NE $LO $NUAN #money http://t.co/WI9wJQCXwA
Haiden Dallas
17 Apr 14 06:34:00
Find the next hot #pennystock $AAN $PL $INCY $DF #investing http://t.co/SCz8humRYW
Ansel Gonzalez
17 Apr 14 06:16:01
#Stock Market Reports on stocks like $GME $NOV $INCY $S #wallstreet http://t.co/AbwMCBLxNT
Krishna Almanzak
17 Apr 14 06:06:22
Best research on #stocks such s $INCY $FOSL $ROC $AMZN #financialnews http://t.co/uZxnUkowGD
Investing Guru
17 Apr 14 05:47:37
Best research on #stocks such s $INCY $WOOF $FRX $ISRG #newsletter http://t.co/NJ8AuHIbMY
Market Int Center
17 Apr 14 05:12:58
Incyte $INCY Showing Resistance Near $45.77 ( http://t.co/PaZ4Fjb8Jq )
Trystan Carson
17 Apr 14 03:57:29
Insider Trading updates on $SPLK $TW $INCY $WTW #moneymanagement http://t.co/LwGE2e5pTe
Jaydan Gelson
17 Apr 14 02:58:53
$HLF #Best #Pennystock research $INCY $V $SLW #money http://t.co/MMznfb2NlR
Maxton Gelson
16 Apr 14 23:47:06
Insider Trading alerts on $DUK $INCY $KRC $IBM I suggest http://t.co/hWxHJxi9hp
EXPstocktrader.com
16 Apr 14 20:33:10
Are the BBs buying this shit? I don't thk so. They are in $PCYC $INCY and several others cheap. Like 87% success -- http://t.co/j4VcsLqrLI
Mark Latimer
16 Apr 14 19:51:36
$INCY Incyte to Report First Quarter http://t.co/L18hy1v6qf
Belia Deleon
16 Apr 14 19:00:08
Are you considering buying $AVB $INCY $LB $LGND Try this http://t.co/mUNkwKNf53
Genie Pike
16 Apr 14 18:46:18
$INCY Incyte to Report First Quarter http://t.co/z4z7JjiRNR
Maryjo Craftm
16 Apr 14 18:26:17
Insider Trading alerts on $CLGX $VRSK $INCY $DF #NASDAQ http://t.co/NMgWjieCzm
Tawanda Friend
16 Apr 14 18:24:50
$INCY Incyte to Report First Quarter http://t.co/11FAWKdEfC
Fausto Tilley
16 Apr 14 18:03:43
$INCY Incyte to Report First Quar http://t.co/hX6P6ZiXai
				
				
  +Follow August 21, 2013 9:20AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.